Company Filing History:
Years Active: 2009
Title: Bruce Eckloff: Innovator in Genetic Research
Introduction
Bruce Eckloff is a notable inventor based in Oronoco, Minnesota. He has made significant contributions to the field of genetic research, particularly in the study of CYP19A1 polymorphisms. His work has implications for understanding various clinical conditions and individual predispositions.
Latest Patents
Eckloff holds a patent for isolated CYP19A1 nucleic acid molecules. This patent includes a nucleotide sequence variant and the nucleotides flanking the sequence variant. Additionally, it describes CYP19A1 allozymes and methods for determining the aromatase status of an individual. These advancements are crucial for assessing predispositions to certain clinical conditions.
Career Highlights
Bruce Eckloff is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research. His work is characterized by a commitment to improving medical understanding through genetic insights.
Collaborations
Eckloff has collaborated with esteemed colleagues such as Richard M. Weinshilboum and Eric O. Wieben. These partnerships have enhanced the depth and impact of his research endeavors.
Conclusion
In summary, Bruce Eckloff is a distinguished inventor whose work in genetic research has the potential to influence clinical practices significantly. His contributions to the understanding of CYP19A1 polymorphisms are invaluable to the medical community.